Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 66Unknown 14Recruiting 10Active not recruiting 9Terminated 6Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia 1

Interventions

blinatumomab 10Cyclophosphamide 6fludarabine 4Vincristine 4Methotrexate 4Dexamethasone 4Cytarabine 4venetoclax 3Whole-Body Irradiation 2Thiotepa 2Therapeutics 2Mercaptopurine 2Exercise 2Busulfan 2ruxolitinib 1revumenib 1ponatinib 1pegaspargase 1olverembatinib 1navitoclax 1fludarabine phosphate 1etoposide phosphate 1capivasertib 1asciminib 1Ultrasonography 1Transplantation 1Prednisolone 1Melphalan 1Levofloxacin 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Mercaptopurine × Clear all
NCT07227584 2025-11-12

ALL Backbone in AYAs

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting
67 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06175702 2023-12-19

LALPh2022

PETHEMA Foundation

Not yet recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡